University of Alberta study sheds light on defect behind multiple sclerosis

Biogen wins patent ruling for its $4 billion multiple sclerosis treatment
March 29, 2017
People Skip Cancer Treatments Drugs Because Of High Prices
March 30, 2017
Show all

University of Alberta study sheds light on defect behind multiple sclerosis

A key protein might trigger a damaging interaction in multiple sclerosis.

Using tissue samples from the brains of deceased MS patients, the researchers identified a key protein that seems to set in motion a damaging interaction that ultimately leads to “cellular suicide.”

“The finding, and this is a very novel finding, of our study is that this protein is highly upregulated in MS brains,” said Thomas Simmen, a cell biology professor who served as co-author of the research.

“Two aspects of the MS phenotype get boosted by having too much of this protein. One is that you have … brain cells undergoing unwanted cell death. And secondly, it will also boost inflammation.”

Read full article: University of Alberta study sheds light on defect behind multiple sclerosis | Edmonton Journal

Read Full Article: University of Alberta study sheds light on defect behind multiple sclerosis | Edmonton Journal

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.